Non-Adherence G20
Conditions
Interventions
Group 1: AdhCare: All patients in this group receive a tailored intervention to improve adherence depending on the individual reasons of non-adherence:
- Standardized informational talk to improve pat
Sponsors
Department of Neurology, Jena University Hospital
Eligibility
Sex/Gender
All
Age
60 Years to No maximum
Inclusion criteria
Inclusion criteria: - The patient is clinically diagnosed with Parkinson‘s disease according to the MDS-criteria - Montreal cognitive assessment (MoCA) = 19/30 points - Patient manages his medication independently - Presence of self-reported non-adherence according to the German Stendal Adherence with Medication Score (SAMS > 1) - Informed consent is obtained from the participant
Exclusion criteria
Exclusion criteria: - Acute psychotic symptoms, delirium - Montral cognitive assessment (MoCA) < 19/30 - Patient is not actively involved in drug management (e.g., bedridden in nursing home) - Inability to provide informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint in this study is motor function assessed with the combined MDS-UPDRS II and MDS-UPDRS III (revised Unified Parkinson's Disease Rating) after 6 months in the control vs. AdhCare arm (Intent-To-Treat). | — |
Secondary
| Measure | Time frame |
|---|---|
| Self-reported adherence (SAMS), Medication adherence scores, Number of Primary Care Visits. We will also qualitatively evaluate the perception of intervention and barriers and facilitators for the implementation. Will be assessed after 3 and 6 month. | — |
Countries
Germany
Contacts
Public ContactHannah Mühlhammer
Department of Neurology, Jena University Hospital
Outcome results
None listed